Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: The Ikaria Study

Journal of Hypertension

Volumn 29, Issue 8, 2011, Pages 1624-1632

  Tsiachris, Dimitris ^a   Chrysohoou, Christina ^a   Oikonomou, Evagelos ^a   Lazaros, George ^a   Dimitriadis, Kyriakos ^a   Maragiannis, Dimitris ^a   Roussos, Dimitris ^a   Andreou, Ioannis ^a   Tsantilas, Apostolos ^a   Christoforatou, Evagelia ^a   Pitsavos, Christos ^a   Panagiotakos, Demosthenes ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

age; echocardiography; electrocardiogram; left ventricular hypertrophy

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY SURFACE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GREECE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 79960623411     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283487780     Document Type: Article

References (33)

1. Hancock EW, Deal BJ, Mirvis DM, Okin P, Kligfield P, Gettes LS, et al., American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; American College of Cardiology Foundation; Heart Rhythm Society. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation 2009; 119:e251-e261.
2. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram: prevalence, incidence and mortality in the Framingham Study. Ann Intern Med 1969; 71:89-105.
3. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease: the Framingham Study. Ann Intern Med 1970; 72:813-822.
4. Sullivan JM, van der Zwaag RV, el-Zeky F, Ramanathan KB, Mirvis DM. Left ventricular hypertrophy: effect on survival. J Am Coll Cardiol 1993; 22:508-513. (Pubitemid 23214565)
5. Pewsner D, Jü ni P, Egger M, Battaglia M, Sundström J, Bachmann LM. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ 2007; 335:711.
6. Okin PM, Wright JT, Nieminen MS, Jern S, Taylor AL, Phillips R, Papademetriou V, et al. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint. Am J Hypertens 2002; 15:663-671. (Pubitemid 34804270)
7. Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlö f B, LIFE Study Group. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients: the losartan intervention for endpoint (LIFE) reduction in hypertension study. Hypertension 2000; 35:13-18. (Pubitemid 30054230)
8. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dahlö f B. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators. Hypertension 2000; 36:766-773.
9. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990; 81:815-820. (Pubitemid 20090377)
10. The Blue Zones (website accessed at August 20, 2010), http://www.bluezones.com/about-the-blue-zones-community.
11. Chrysohoou C, Tsitsinakis G, Siasos G, Psaltopoulou T, Galiatsatos N, Metaxa V. Fish consumption moderates depressive symptomatology, in elderly men and women from the IKARIA study. Cardiol Res Pract 2011:219578.
12. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987; 317:1098.
13. Schnell O, Otter W, Standl E. The Munich Myocardial Infarction Registry: translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, prediabetes, and cardiovascular disease into clinical practice. Diabetes Care 2009; 32:S326-S330.
14. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 37:161-186.
15. Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sexspecific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation 1987; 75:565-572. (Pubitemid 17026046)
16. Gubner R, Ungerleider HE. Electrocardiographic criteria of left ventricular hypertrophy. Arch Intern Med 1943; 72:196-209.
17. Lewis T. Observations upon ventricular hypertrophy with especial reference to preponderance of 1 or other chamber. Heart 1914; 5:367.
18. Molloy TJ, Okin PM, Devereux RB, Kligfield P. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage duration product. J Am Coll Cardiol 1992; 20:1180-1186.
19. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage duration products. J Am Coll Cardiol 1995; 25:417-423.
20. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463. (Pubitemid 41821197)
21. de Simone G, Muiesan ML, Ganau A, Longhini C, Verdecchia P, Palmieri V, et al. Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: the RES trial. Working Group on Heart and Hypertension of the Italian Society of Hypertension. Reliability of M-mode Echocardiographic Studies. J Hypertens 1999; 17:1955-1963. (Pubitemid 30345337)
22. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458. (Pubitemid 16119719)
23. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187. (Pubitemid 46924065)
24. Cuspidi C, Giudici V, Negri F, Meani S, Sala C, Zanchetti A, Mancia G. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height [2.7]. J Hypertens 2009; 27:2465-2471.
25. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 97:48-54. (Pubitemid 28036154)
26. Prineas RJ, Rautaharju PM, Grandits G, Crow R, MRFIT Research Group. Independent risk for cardiovascular disease predicted by modified continuous score electrocardiographic criteria for 6-year incidence and regression of left ventricular hypertrophy among clinically disease free men: 16-year follow-up for the Multiple Risk Factor Intervention Trial. J Electrocardiol 2001; 34:91-101. (Pubitemid 32436589)
27. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, et al., for the LIFE Study Investigators. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 2004; 292:2343-2349. (Pubitemid 39491918)
28. Fagard RH, Staessen JA, Thijs L, Celis H, Birkenhä ger WH, Bulpitt CJ. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Prognostic Hypertension 2004; 44:459-464.
29. Okin PM, Roman MJ, Devereux RB, Kligfield P. Gender differences and the electrocardiogram in left ventricular hypertrophy. Hypertension 1995; 25:242-249.
30. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of left ventricular hypertrophy: relationship of test performance to body habitus. J Electrocardiol 1996; 29:256-261.
31. Okin PM, Roman MJ, Devereux RB, Kligfield P. Time-voltage area of the QRS for the identification of left ventricular hypertrophy. Hypertension 1996; 27:251-258. (Pubitemid 26045923)
32. Sohaib SM, Payne JR, Shukla R, World M, Pennell DJ, Montgomery HE. Electrocardiographic (ECG) criteria for determining left ventricular mass in young healthy men; data from the LARGE Heart study. J Cardiovasc Magn Reson 2009; 11:2.
33. Levy D, Bailey JJ, Garrison RJ, Horton MR, Balkus SM, Lyons D, Castelli WP. Electrocardiographic changes with advancing age. J Electrocardiol 1987; 20:44-47.